Pharma & MedTech industry special: Individual solutions for current challenges

Bayer, BioNTech, Biotronik, Boehringer Ingelheim, B. Braun, Dräger, Fresenius, Heraeus Medical, Merck, Miltenyi Biotec, Philips, Sartorius, Siemens, Stada, Zeiss - the list of German pharmaceutical and medical technology companies is long. The challenges that these companies face are also extensive. This is because they have to comply with a large number of legal and regulatory requirements. However, they often lack the necessary personnel. As an interim management provider, Deutsche Interim AG naturally also places experts in the pharmaceutical and medical technology sectors with companies. We have spoken to some of these interim professionals and created the pharma and medical technology sector special for you. In it, we not only focus on the current challenges and trends in the pharmaceutical and medtech industry. Our specialist interim managers also present their tried-and-tested solutions in various specialist areas.

The pharmaceutical industry has a long tradition in Germany. Many pharmaceutical and medical technology companies hold leading international market positions (in some areas) and are therefore an important pillar of the economy. But there are challenges. For example, reliable quality management is essential. This is because medtech and pharmaceutical companies operate in a highly regulated environment. They are therefore required to quickly implement constantly changing legal requirements and ensure regulatory compliance throughout the company. In addition, the ongoing digital transformation, which is accompanied by a disruptive change in production, including process-related changes, is an ongoing issue that German companies must address at full speed. It is also essential to deal with the EU Supply Chain Act. This is because it applies to pharmaceutical and medical technology companies that have branches in an EU member state, employ more than 500 people there and generate over 150 million euros in annual turnover worldwide or 40 million euros in the European single market.

ifo economic survey: highly qualified personnel are in short supply

Highly qualified and experienced personnel are needed to overcome these and other challenges. According to the ifo Institute's economic survey from March 2024, around 36% of the companies surveyed are lacking precisely this type of workforce - despite the weakening economy. This is where Deutsche Interim AG's Interim Managers come into play: We provide competent and quickly available experts for temporary assignments - including to your company. These experts are used to adapting quickly to new situations, analyzing with great expertise and implementing solutions that are both pragmatic and sustainable.

"Pharma and medical technology industry special" for free download

In our Pharma and medical technology industry special, you can find out more about the current challenges and trends in the pharma and medtech industry. In addition, our interim professionals specializing in pharma and medtech will present their proven solutions.

The topics at a glance:

• Value chain management: How to successfully transform into a value-oriented company
• Circular economy: How medical technology and pharmaceutical companies benefit from greater sustainability
• Post-merger integration: How company mergers succeed without affecting day-to-day business
• Omnichannel marketing:What added value digital sales opens up for pharmaceutical companies
• Data-driven work: Why pharmaceutical companies should take their cue from Formula 1
• Automation in medical technology: How digital twins and surgical robots are revolutionizing the healthcare industry

Want to learn more? Download the complete Pharmaceutical and medical technology industry special free of charge and get to know the solutions of our specialized interim managers!